Drug Shortage Report for MYLAN-ALMOTRIPTAN
Report ID | 27110 |
Drug Identification Number | 02398443 |
Brand name | MYLAN-ALMOTRIPTAN |
Common or Proper name | ALMOTRIPTAN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ALMOTRIPTAN |
Strength(s) | 12.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 6BL |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-03-05 |
Actual start date | 2018-03-07 |
Estimated end date | 2019-01-18 |
Actual end date | 2019-01-21 |
Shortage status | Resolved |
Updated date | 2019-01-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-10-26 | French | Compare |
v1 | 2017-10-26 | English | Compare |